Literature DB >> 12552005

Early induction and maintenance of Env-specific T-helper cells following human immunodeficiency virus type 1 infection.

Uma Malhotra1, Sarah Holte, Tuofu Zhu, Elizabeth Delpit, Claire Huntsberry, Alessandro Sette, Raj Shankarappa, Janine Maenza, Lawrence Corey, M Juliana McElrath.   

Abstract

Mounting evidence points to a role for CD4+ T-helper (Th) cell activities in controlling human immunodeficiency virus type 1 (HIV-1) infection. To determine the induction and evolution of Th responses following acute infection, we prospectively analyzed Env- and Gag-specific Th responses longitudinally for 92 patients with acute (n = 28) or early (n = 64) HIV-1 infection (median, 55 days postinfection [DPI]). The probability of detecting HIV-1-specific lymphoproliferative responses was remarkably low, and when present, the responses were more likely to be Gag specific than Env specific (16 versus 5%). Env-specific responses were significantly more common in patients presenting at <30 DPI than in those presenting at 30 to 365 DPI (21 versus 0.5%, P = 0.001). By contrast, Gag-specific responses occurred with similar frequencies among subjects presenting at <30 DPI and 30 to 365 DPI (13 versus 17%, P = 0.6). After treatment, and regardless of the duration of infection before therapy, Gag-specific Th responses predominated. Furthermore, some acutely infected subjects lost detectable Env-specific Th proliferative responses, which failed to reemerge upon treatment. Detailed analysis for one such subject revealed Env-specific lymphoproliferation at 11 DPI but no detectable Env-specific lymphoproliferation or ex vivo gamma interferon (IFN-gamma) secretion at multiple subsequent time points. Env-specific CD4+ T-cell clones from 11 DPI recognized six epitopes in both conserved and variable regions within gp120 and gp41, exhibited major histocompatibility complex-restricted cytotoxicity, and secreted high levels of antiviral cytokines. T-cell receptor clonal transcript analyses and autologous virus sequencing revealed that Th cells induced during acute infection were maintained and there were no Th escape mutations. Subsequent analysis for this subject and six of seven others revealed detectable IFN-gamma-secreting cells, but only following in vitro gp160 stimulation. In summary, we conclude that Env-specific Th responses are elicited very early in acute infection and may precede Gag-specific responses. The inability to detect Env-specific Th responses over time and despite antiretroviral therapy may reflect low frequencies and impaired proliferative capacity, and viral escape is not necessary for this to occur.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12552005      PMCID: PMC141076          DOI: 10.1128/jvi.77.4.2663-2674.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Rapid screening of T-cell receptor (TCR) variable gene usage by multiplex PCR: application for assessment of clonal composition.

Authors:  Y Akatsuka; E G Martin; A Madonik; A A Barsoukov; J A Hansen
Journal:  Tissue Antigens       Date:  1999-02

2.  Safety of autologous, ex vivo-expanded human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte infusion in HIV-infected patients.

Authors:  J Lieberman; P R Skolnik; G R Parkerson; J A Fabry; B Landry; J Bethel; J Kagan
Journal:  Blood       Date:  1997-09-15       Impact factor: 22.113

3.  A novel method for real time quantitative RT-PCR.

Authors:  U E Gibson; C A Heid; P M Williams
Journal:  Genome Res       Date:  1996-10       Impact factor: 9.043

4.  Epitope specificity of MHC restricted cytotoxic T lymphocytes induced by candidate HIV-1 vaccine.

Authors:  R P Johnson; S A Hammond; A Trocha; R F Siliciano; B D Walker
Journal:  AIDS Res Hum Retroviruses       Date:  1994       Impact factor: 2.205

5.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.

Authors:  J D Thompson; D G Higgins; T J Gibson
Journal:  Nucleic Acids Res       Date:  1994-11-11       Impact factor: 16.971

6.  Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia.

Authors:  E S Rosenberg; J M Billingsley; A M Caliendo; S L Boswell; P E Sax; S A Kalams; B D Walker
Journal:  Science       Date:  1997-11-21       Impact factor: 47.728

7.  Antagonism of vaccine-induced HIV-1-specific CD4+ T cells by primary HIV-1 infection: potential mechanism of vaccine failure.

Authors:  S J Kent; P D Greenberg; M C Hoffman; R E Akridge; M J McElrath
Journal:  J Immunol       Date:  1997-01-15       Impact factor: 5.422

8.  Several common HLA-DR types share largely overlapping peptide binding repertoires.

Authors:  S Southwood; J Sidney; A Kondo; M F del Guercio; E Appella; S Hoffman; R T Kubo; R W Chesnut; H M Grey; A Sette
Journal:  J Immunol       Date:  1998-04-01       Impact factor: 5.422

9.  HIV-1 induces cytotoxic T lymphocytes in the cervix of infected women.

Authors:  L Musey; Y Hu; L Eckert; M Christensen; T Karchmer; M J McElrath
Journal:  J Exp Med       Date:  1997-01-20       Impact factor: 14.307

10.  CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response.

Authors:  P Borrow; A Tishon; S Lee; J Xu; I S Grewal; M B Oldstone; R A Flavell
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

View more
  16 in total

Review 1.  Preserving HIV-specific T cell responses: does timing of antiretroviral therapy help?

Authors:  Bernard J C Macatangay; Charles R Rinaldo
Journal:  Curr Opin HIV AIDS       Date:  2015-01       Impact factor: 4.283

2.  SIV Infection-Mediated Changes in Gastrointestinal Bacterial Microbiome and Virome Are Associated with Immunodeficiency and Prevented by Vaccination.

Authors:  Scott A Handley; Chandni Desai; Guoyan Zhao; Lindsay Droit; Cynthia L Monaco; Andrew C Schroeder; Joseph P Nkolola; Megan E Norman; Andrew D Miller; David Wang; Dan H Barouch; Herbert W Virgin
Journal:  Cell Host Microbe       Date:  2016-03-09       Impact factor: 21.023

3.  Enhanced detection of human immunodeficiency virus type 1 (HIV-1) Nef-specific T cells recognizing multiple variants in early HIV-1 infection.

Authors:  Uma Malhotra; Fusheng Li; Jessica Nolin; Megan Allison; Hong Zhao; James I Mullins; Steve Self; M Juliana McElrath
Journal:  J Virol       Date:  2007-02-28       Impact factor: 5.103

4.  The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelope.

Authors:  Mark S de Souza; Silvia Ratto-Kim; Weerawan Chuenarom; Alexandra Schuetz; Somsak Chantakulkij; Bessara Nuntapinit; Anais Valencia-Micolta; Doris Thelian; Sorachai Nitayaphan; Punnee Pitisuttithum; Robert M Paris; Jaranit Kaewkungwal; Nelson L Michael; Supachai Rerks-Ngarm; Bonnie Mathieson; Mary Marovich; Jeffrey R Currier; Jerome H Kim
Journal:  J Immunol       Date:  2012-04-23       Impact factor: 5.422

5.  Antigen stimulation induces HIV envelope gp120-specific CD4(+) T cells to secrete CCR5 ligands and suppress HIV infection.

Authors:  Gurvinder Kaur; Michael Tuen; Diana Virland; Sandra Cohen; Narinder K Mehra; Christian Münz; Sayed Abdelwahab; Alfredo Garzino-Demo; Catarina E Hioe
Journal:  Virology       Date:  2007-09-04       Impact factor: 3.616

6.  Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides.

Authors:  Daniel E Kaufmann; Paul M Bailey; John Sidney; Bradford Wagner; Philip J Norris; Mary N Johnston; Lisa A Cosimi; Marylyn M Addo; Mathias Lichterfeld; Marcus Altfeld; Nicole Frahm; Christian Brander; Alessandro Sette; Bruce D Walker; Eric S Rosenberg
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

7.  A novel liposome-based adjuvant CAF01 for induction of CD8(+) cytotoxic T-lymphocytes (CTL) to HIV-1 minimal CTL peptides in HLA-A*0201 transgenic mice.

Authors:  Gregers Jacob Gram; Ingrid Karlsson; Else Marie Agger; Peter Andersen; Anders Fomsgaard
Journal:  PLoS One       Date:  2009-09-11       Impact factor: 3.240

8.  Induction of Gag-specific CD4 T cell responses during acute HIV infection is associated with improved viral control.

Authors:  Miriam Schieffer; Heiko K Jessen; Alexander F Oster; Franco Pissani; Damien Z Soghoian; Richard Lu; Arne B Jessen; Carmen Zedlack; Bruce T Schultz; Isaiah Davis; Srinika Ranasinghe; Eric S Rosenberg; Galit Alter; Ralf R Schumann; Hendrik Streeck
Journal:  J Virol       Date:  2014-04-16       Impact factor: 5.103

9.  Major histocompatibility complex class II molecule-human immunodeficiency virus peptide analysis using a microarray chip.

Authors:  Simani Gaseitsiwe; Davide Valentini; Raija Ahmed; Shahnaz Mahdavifar; Isabelle Magalhaes; Johannes Zerweck; Mike Schutkowski; Emmanuel Gautherot; Felix Montero; Anneka Ehrnst; Marie Reilly; Markus Maeurer
Journal:  Clin Vaccine Immunol       Date:  2009-02-18

Review 10.  Decimated or missing in action: CD4+ T cells as targets and effectors in the pathogenesis of primary HIV infection.

Authors:  Anthony D Kelleher; John J Zaunders
Journal:  Curr HIV/AIDS Rep       Date:  2006-02       Impact factor: 5.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.